~~<i id='D03011CFD6'><strike id='D03011CFD6'><tt id='D03011CFD6'><pre id='D03011CFD6'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

focus

comprehensive

author：leisure time 2025-10-01 01:50:23 - browse：34122

A tumor invasion into vein in a case of colorectal cancer -- cancer coverage from STAT — A tumor invasion into a vein in a case of colorectal cancer. Wikimedia Commons

When both the nurse and the doctor broke down in tears as they delivered the news, Chris Gosline knew that something difficult lay ahead.

It was 5 a.m., after a long night in the emergency department at Beverly Hospital, where he’d gone for help with severe pain in his shoulder. A scan had detected tumors on his liver. Turns out, there’s a nerve connection that makes shoulder pain a possible sign of liver disease.

Further testing over the next couple of weeks clarified the cause: Gosline had stage 4 colorectal cancer, which had spread to his liver.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Virginia high school admissions case could be legal follow
Next article： Readout Newsletter: What is Casgevy? Does Wegovy hurt muscle?

entertainment

hotspot

entertainment

Wikipedia

AphotoillustrationshowingaselectionoffrontpagescoveringthenewsofKingCharlesbeingdiagnosedwithanunspe

WSS

In key trial, Verve's treatment lowers cholesterol levels in patients

Weight loss drug Wegovy cuts risk of heart attacks in milestone trial

Congress must reauthorize a committee to support older Americans

A daunting task: navigating dual Medicare, Medicaid eligibility

FDA's Woodcock to retire early next year

Morphosys mixed study results for blood cancer drug

focus

comprehensive

entertainment

Apple is now the first public company to be valued at $3 trillion

A ‘polypill’ could sharply reduce cardiovascular disease in the U.S.

Malaria cases in Florida and Texas: Here’s what you need to know

Gilead might be held responsible for not developing a drug

State Dept. review finds Biden bears some blame for Afghanistan failures

Senators start work on Medicare physician payment reform

Activists slam private health insurers over coverage restrictions

Why did Pfizer dish out millions for a Super Bowl ad?

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Readout Newsletter: Biogen, Rocket Pharma, KalVista, and more

hotspot

In key trial, Verve's treatment lowers cholesterol levels in patients

What we’ve learned from the Aduhelm mess

A daunting task: navigating dual Medicare, Medicaid eligibility

Gilead acquiring CymaBay and its liver disease drug for $4.3 billion

A disappointing year of Humira biosimilars

What we’ve learned from the Aduhelm mess

hotspot

hotspot

entertainment

Wikipedia